FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Enzyme discovery offers new direction in diabetes

A team of Australian scientists has found an enzyme in diabetics that prevents them from producing insulin. The researchers say that they intend to start working with drug developers to block PKCepsilon, raising the possibility of a simple, effective method for treating diabetes. Observers also noted that the advancement could create a therapy that would protect people at high risk from ever developing Type 2 diabetes. In an animal study, the team developed genetically modified mice without the enzyme, and found that they didn't develop diabetes even after gaining a significant amount of weight on a high-fat diet.

- see the release on the discovery
- read the the report from ABC

Related Articles:
New way to creating enzymes. Report
Diabetes epidemic triggers soaring drug market. Report
Diabetes therapies move into the research spotlight. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Research Email Newsletter:
Be the first to comment
More stories about type II diabetes   Diabetes   Enzymes   PKCepsilon  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.